IBRX EBITDA Margin
Immunitybio Inc · EBITDA Margin
IBRX EBITDA Margin
Latest reported-538.46%period ending
IBRX EBITDA Margin (-263.17% → -538.46%)
Annual ebitda margin
High-resolution chart · PNG
IBRX ebitda margin history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| -197.3351% | |
| -1,793.374% | |
| -76,955.4662% | |
| -146,617.0833% | |
| -34,341.7559% | |
| -33,755.3719% | |
| -120,523.2558% | |
| -184,555.3191% | |
| -201,626.6667% | |
| -267,518.1818% | |
| -99,875% | |
| -885.6474% | |
| -263.1667% |